Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Sarcoma 1Retinoblastoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroblastoma 1Medulloblastoma 1Lymphoma 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Filgrastim 10Temozolomide 5Peripheral Blood Stem Cell Transplantation 5sargramostim 4Carboplatin 4Thiotepa 3Cyclophosphamide 3Busulfan 3Topotecan 2Radiotherapy 2Oxaliplatin 2Melphalan 2Irinotecan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Cyproheptadine 2Cisplatin 2trioctyl phosphine oxide 1palbociclib 1olaparib 1ixabepilone 1ispinesib 1gallium Ga 68 dotatate 1exatecan 1etoposide phosphate 1becatecarin 1alvocidib 1aldesleukin 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Familial ependymoma × becatecarin × Sarcoma × Clear all
NCT00006102 2013-02-05

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
200 enrolled
CNSLymphoidOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Lymphoma, Medulloblastoma, Neuroblastoma, Oligodendroglioma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡